Keywords:
Metabolic disorders, Diagnostic procedure, MR, Cardiac
Authors:
C. M. Berzovini1, R. Faletti2, M. Gatti2, E. Caramia2, E. Vanni1; 1Torino/IT, 2Turin/IT
References
1) Bhatia LS1,
Curzen NP et al.
“Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?”,
Eur Heart J.
2012 May;33(10):1190-200.
2) Ballestri S,
Lonardo A et al.
“Risk of cardiovascular,
cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease”,
World J Gastroenterol.
2014 Feb 21;20(7):1724-45.
3) Sacks HS1,
Fain JN.,
“Human epicardial adipose tissue: a review”,
Am Heart J.
2007 Jun;153(6):907-17.
4) Elming MB1,
Lønborg J,
et al.
“Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging.” Int J Cardiovasc Imaging.
2013 Aug;29(6):1401-7.
5) Nelson AJ1,
Worthley MI et al.
“Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume”,
J Cardiovasc Magn Reson.
2009 May 5;11:15.
6) Flachskampf FA1,
Biering-Sørensen T et al,
“Cardiac Imaging to Evaluate Left Ventricular Diastolic Function” JACC Cardiovasc Imaging.
2015 Sep;8(9):1071-93.
7) Daneshvar D1,
Wei J,
Tolstrup K,
“Diastolic dysfunction: improved understanding using emerging imaging techniques” Am Heart J.
2010 Sep;160(3):394-404.